Molecular Templates, Inc.
Other OTCTotal Valuation
Molecular Templates, Inc. carries a market capitalization of 658.00, placing it among publicly traded companies globally. Its enterprise value stands at -831,931.42, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 658.00 |
| Enterprise Value | -831,931.42 |
Share Statistics
Molecular Templates, Inc. currently has 6.58M shares outstanding.
| Shares Outstanding | 6.58M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 0.02, and the price-to-book ratio stands at 0.00.
| PE Ratio | N/A |
| PS Ratio | 0.02 |
| PB Ratio | 0.00 |
| P/TBV Ratio | 0.06 |
| P/FCF Ratio | -0.02 |
| P/OCF Ratio | -0.02 |
Enterprise Valuation
| EV / Sales | 0.98 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Molecular Templates, Inc. maintains a current ratio of 1.56, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 117.99, indicating elevated leverage, while an interest coverage ratio of -100.58 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.56 |
| Quick Ratio | 1.36 |
| Debt / Equity | 117.99 |
| Debt / EBITDA | -0.60 |
| Interest Coverage | -100.58 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -50.24 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 1.55 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
| Income Tax | -11,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
Molecular Templates, Inc.'s stock has declined approximately -99.89051% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.26.
| Beta (5Y) | N/A |
| 52-Week Price Change | -99.89051% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.26 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Molecular Templates, Inc. generated 23.48M in revenue and converted that into -15.63M in net income, yielding earnings per share of -2.51. EBITDA reached -13.98M, while operating income came in at -18.85M.
| Revenue | 23.48M |
| Gross Profit | N/A |
| Operating Income | -18.85M |
| Pretax Income | -15.64M |
| Net Income | -15.63M |
| EBITDA | -13.98M |
| EBIT | -18.85M |
| Earnings Per Share (EPS) | -2.51 |
Balance Sheet
Molecular Templates, Inc. holds 9.66M in cash and equivalents against 8.39M in total debt, resulting in a net debt position of -9.66M. Total book value stands at -460.41M, with working capital of 4.34M providing operational flexibility.
| Cash & Cash Equivalents | 9.66M |
| Total Debt | 8.39M |
| Net Debt | -9.66M |
| Equity (Book Value) | -460.41M |
| Book Value Per Share | -81.13 |
| Working Capital | 4.34M |
Cash Flow
Molecular Templates, Inc. produced -23.92M in operating cash flow over the past twelve months.
| Operating Cash Flow | -23.92M |
| Capital Expenditures | N/A |
| Free Cash Flow | -23.92M |
| FCF Per Share | -4.22 |
Margins
Molecular Templates, Inc. operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of -80.28 and net profit margin of -66.54 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | -80.28 |
| Pretax Margin | -66.59 |
| Profit Margin | -66.54 |
| EBITDA Margin | -59.53 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -4,225.54 |
| FCF Yield | -5,015.30 |
Stock Splits
Molecular Templates, Inc.'s most recent stock split took place on August 14, 2023 with a 15:1 split ratio.
| Last Split Date | 8/14/2023 |
| Split Ratio | 15:1 |
Scores
Molecular Templates, Inc. posts an Altman Z-Score of -25.39, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -25.39 |